Solifenacin

Common brands: Vesicare Ls, Vesicare, Vitamin D, Ecotrin, Aspirin 325

Top reporter: Astellas Pharma Us, Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Proton Pump Inhibitor [EPC]Benzodiazepine [EPC]Provitamin D2 Compound [EPC]Platelet Aggregation Inhibitor [EPC]
25,864
Total Reports
3,897
Serious Reports
1,351
Death Reports
30
Reported Reactions
Death Report Ratio: High (5.22%)

Patient Demographics

Male
7,211
Female
17,533

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Solifenacin.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 3,610
14.4%
2 CONSTIPATION 1,622
6.5%
3 DRY MOUTH 1,620
6.5%
4 FATIGUE 1,287
5.1%
5 OFF LABEL USE 1,247
5.0%
6 FALL 1,231
4.9%
7 DIZZINESS 1,041
4.2%
8 NAUSEA 903
3.6%
9 HEADACHE 865
3.5%
10 VISION BLURRED 789
3.2%
11 URINARY TRACT INFECTION 774
3.1%
12 DIARRHOEA 730
2.9%
13 ASTHENIA 667
2.7%
14 MALAISE 661
2.6%
15 PAIN 658
2.6%
16 GAIT DISTURBANCE 611
2.4%
17 DYSPNOEA 608
2.4%
18 DEATH 517
2.1%
19 CONFUSIONAL STATE 516
2.1%
20 INSOMNIA 484
1.9%
21 PNEUMONIA 483
1.9%
22 URINARY INCONTINENCE 480
1.9%
23 VOMITING 473
1.9%
24 PRURITUS 472
1.9%
25 SOMNOLENCE 470
1.9%
26 PAIN IN EXTREMITY 465
1.9%
27 URINARY RETENTION 447
1.8%
28 RASH 435
1.7%
29 POLLAKIURIA 431
1.7%
30 ARTHRALGIA 430
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.